Joong Sup Shim

6.6k total citations · 2 hit papers
85 papers, 5.0k citations indexed

About

Joong Sup Shim is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Joong Sup Shim has authored 85 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 28 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Joong Sup Shim's work include Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (14 papers) and Histone Deacetylase Inhibitors Research (8 papers). Joong Sup Shim is often cited by papers focused on Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (14 papers) and Histone Deacetylase Inhibitors Research (8 papers). Joong Sup Shim collaborates with scholars based in Macao, South Korea and United States. Joong Sup Shim's co-authors include Jun O. Liu, Ho Jeong Kwon, Bo Huang, Qian Chen, Duojia Pan, Yi Liu‐Chittenden, Robert A. Anders, Eun Ju Yang, Hye Jin Jung and Jin Hee Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Joong Sup Shim

83 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

2012 1.1k citations Joong Sup Shim, Jun O. Liu et al. profile →
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

2016 624 citations Joong Sup Shim et al. profile →

Peers

Countries citing papers authored by Joong Sup Shim

Since Specialization

Citations

This map shows the geographic impact of Joong Sup Shim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joong Sup Shim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joong Sup Shim more than expected).

Fields of papers citing papers by Joong Sup Shim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joong Sup Shim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joong Sup Shim. The network helps show where Joong Sup Shim may publish in the future.

Co-authorship network of co-authors of Joong Sup Shim

This figure shows the co-authorship network connecting the top 25 collaborators of Joong Sup Shim. A scholar is included among the top collaborators of Joong Sup Shim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joong Sup Shim. Joong Sup Shim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis 2025 ·Cell Death and Differentiation ·(unknown), (unknown), Yilin He, (unknown), (unknown), Yongfeng Liu, YiJiang Song, Aimin Li, Zhen Wang, Yingnan Yu, (unknown), Side Liu, Joong Sup Shim, Changjie Wu	3
2	Inhibition of GSK3β is synthetic lethal with FHIT loss in lung cancer by blocking homologous recombination repair 2025 ·Experimental & Molecular Medicine ·Shishi Tao, (unknown), Eun Ju Yang, Guowen Ren, Changxiang Shi, Lijie Chen, Liang Chen, Joong Sup Shim	2
3	BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21^CIP1/WAF1 2024 ·International Journal of Biological Sciences ·Guowen Ren, (unknown), Yue Pu, Eun Ju Yang, Shishi Tao, (unknown), (unknown), Wenli Zhu, (unknown), Guanghui Luo, Chu‐Xia Deng, Joong Sup Shim	1
4	ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones 2023 ·International Journal of Biological Sciences ·Shishi Tao, Eun Ju Yang, Guanghui Zong, (unknown), Guowen Ren, (unknown), Liang Chen, Ho Jeong Kwon, Jianhong Zhou, Zhijian Hu, (unknown), Qingyang Zhang, Yuchun Du, Wei Shi, Joong Sup Shim	3
5	TRIM family proteins: roles in proteostasis and neurodegenerative diseases 2022 ·Open Biology ·Yan Zhu, Lukman O. Afolabi, Xiaochun Wan, Joong Sup Shim, Liang Chen	31
6	Small Activating RNA Modulation of the G Protein‐Coupled Receptor for Cancer Treatment 2022 ·Advanced Science ·(unknown), Ke Ran, Qingyu Zhang, Wenjun Lan, (unknown), (unknown), (unknown), Yifan Jiang, Jing Wu, Shuai Liu, Alice S.T. Wong, Joong Sup Shim, Xuanjun Zhang, Ruiyu Xie, Nelson Dusetti, Juan Iovanna, Nagy Habib, Ling Peng, Leo Tsz On Lee	18
7	Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein 2020 ·Autophagy ·Hui‐Yun Hwang, Joong Sup Shim, Dasol Kim, Ho Jeong Kwon	84
8	Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F 2020 ·The Journal of Organic Chemistry ·Guanghui Zong, Zhijian Hu, (unknown), (unknown), Jianhong Zhou, Sarah O’Keefe, (unknown), Joong Sup Shim, Yuchun Du, Stephen High, Wei Shi	16
9	Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking 2018 ·International Journal of Biological Sciences ·Junfang Lyu, Eun Ju Yang, Sarah A. Head, Nana Ai, Baoyuan Zhang, Changjie Wu, (unknown), (unknown), (unknown), Shaolin Zhang, Kin Yip Tam, Yongjun Dang, Ho Jeong Kwon, Wei Ge, Jun O. Liu, Joong Sup Shim	22
10	Divergence of Antiangiogenic Activity and Hepatotoxicity of Different Stereoisomers of Itraconazole 2016 ·Clinical Cancer Research ·Joong Sup Shim, (unknown), Namandjé N. Bumpus, Sarah A. Head, Kalyan Kumar Pasunooti, Eun Ju Yang, (unknown), Wei Shi, Jun O. Liu	13
11	Purpurin inhibits adipocyte-derived leucine aminopeptidase and angiogenesis in a zebrafish model 2014 ·Biochemical and Biophysical Research Communications ·(unknown), Joong Sup Shim, Beom Seok Kim, Hye Jin Jung, Tae-Lin Huh, Ho Jeong Kwon	19
12	Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir 2012 ·JNCI Journal of the National Cancer Institute ·Joong Sup Shim, Rajini Rao, Kristin Beebe, Len Neckers, (unknown), Rita Nahta, Jun O. Liu	66
13	A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment 2011 ·Cancer Discovery ·Elizabeth A. Platz, Srinivasan Yegnasubramanian, Jun O. Liu, Curtis R. Chong, Joong Sup Shim, Stacey A. Kenfield, Meir J. Stampfer, Walter C. Willett, Edward L. Giovannucci, William G. Nelson	141
14	Terpestacin Inhibits Tumor Angiogenesis by Targeting UQCRB of Mitochondrial Complex III and Suppressing Hypoxia-induced Reactive Oxygen Species Production and Cellular Oxygen Sensing 2010 ·Journal of Biological Chemistry ·Hye Jin Jung, Joong Sup Shim, Jiyong Lee, Young Mi Song, Ki Cheong Park, Seung Hoon Choi, Nam Doo Kim, Jeong Hyeok Yoon, Paul T. Mungai, Paul T. Schumacker, Ho Jeong Kwon	101
15	Potent inhibition of in vivo angiogenesis and tumor growth by a novel cyclooxygenase‐2 inhibitor, enoic acanthoic acid 2007 ·Cancer Science ·Hye Jin Jung, Joong Sup Shim, Young‐Ger Suh, Young‐Myeong Kim, Mayumi Ono, Ho Jeong Kwon	15
16	Coordinated transcriptional regulation of calmegin, a testis-specific molecular chaperon, by histone deacetylase and CpG methyltransferase 2005 ·Experimental & Molecular Medicine ·Dong Hoon Kim, Joong Sup Shim, Ho Jeong Kwon	7
17	Chemical genetics for therapeutic target mining 2004 ·Expert Opinion on Therapeutic Targets ·Joong Sup Shim, Ho Jeong Kwon	13
18	Apicularen A, a Macrolide from Chondromyces sp., Inhibits Growth Factor Induced In Vitro Angiogenesis 2002 ·Journal of Microbiology and Biotechnology ·Ho Jeong Kwon, Dong Hoon Kim, Joong Sup Shim, Jong Woong Ahn	11
19	Microarray‐based Analysis of Anti‐angiogenic Activity of Demethoxycurcumin on Human Umbilical Vein Endothelial Cells: Crucial Involvement of the Down‐regulation of Matrix Metalloproteinase 2002 ·Japanese Journal of Cancer Research ·Jin Hee Kim, Joong Sup Shim, (unknown), Kyu‐Won Kim, Sun Young Rha, Hyun Cheol Chung, Ho Jeong Kwon	57
20	Articles : Curcumin - Induced Apoptosis of A - 431 Cells Involves Caspase-3 Activation 2001 ·BMB Reports ·Joong Sup Shim, (unknown), Sangshin Park, (unknown), (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact